Investment Rating - The report maintains a "Buy" rating for companies in the semiconductor equipment and robotics sectors, highlighting strong growth potential in these areas [1][4][35]. Core Insights - The semiconductor equipment sector is expected to benefit from accelerated platformization and technological upgrades, with major companies launching new products at the SEMICON exhibition [1]. - The demand for optical modules is surging due to AI developments, leading to a high demand for automation equipment in the assembly process [2][3]. - The robotics industry is experiencing significant growth, particularly with the upcoming IPO of Yuzhu Technology, which has shown impressive revenue growth and profitability [4]. Summary by Sections Semiconductor Equipment - Major companies like North China Innovation and Zhongwei Company are launching advanced equipment, enhancing their product offerings in etching and deposition technologies [1]. - The report emphasizes the importance of platform-based equipment manufacturers and low domestic production rate equipment suppliers as key investment targets [1][24]. Optical Communication Equipment - The report notes that AI-driven demand is pushing the optical module market towards higher specifications, with a shift from 400G to 800G and 1.6T products [2][3]. - Automation in the assembly of optical modules is becoming essential due to the increasing complexity and precision required in production [3]. Robotics Industry - Yuzhu Technology's IPO materials reveal significant revenue growth, with a notable increase in sales of humanoid and quadruped robots [4]. - The report suggests that the robotics sector is poised for recovery and growth, particularly with the anticipated release of Tesla's V3 robot [4]. Investment Recommendations - The report recommends a diversified portfolio including companies like North China Innovation, Zhongwei Company, and Yuzhu Technology, which are positioned to benefit from industry trends [1][4][35].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 佈 全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責 任。 HAITIAN INTERNATIONAL HOLDINGS LIMITED 海天國際控股有限公司 （於 開 曼 群 島 註 冊 成 立 的 有 限 公 司） （股 份 代 號：1882） 有關建議委任獨立非執行董事的補充公佈 茲 提 述 本 公 司 日 期 為 二 零 二 六 年 三 月 十 六 日 的 公 佈，內 容 有 關（其 中 包 括）建 議 委任石建輝先生及貝洪俊女士為獨立非執行董事（「該公佈」）。除 文 義 另 有 所 指 外，本 公 佈 所 用 詞 彙 具 有 該 公 佈 所 界 定 的 涵 義。 石建輝先生 董事會謹此根據上市規則第13.51(2)(h)條，就 上 海 證 券 交 易 所 於 二 零 二 三 年 八 月 三日作出的決定（《紀 律 處 分 決 定 書》[2023]87號）（「二零二三年上交所決定」）提 供 有 關 貝 ...

Investment Rating - The report maintains a "Buy" rating for the mechanical equipment industry, with a focus on AI and mechanical equipment investment opportunities [1]. Core Insights - The report emphasizes the potential of AI-driven mechanical equipment, particularly in the robotics sector, where companies like Yushu Technology are showing significant growth in revenue and profitability [1]. - The GTC conference highlighted the increasing demand for AI computing power, which is expected to drive growth in PCB and liquid cooling segments [2]. - The solar equipment sector is poised to benefit from Tesla's procurement of large-scale photovoltaic equipment and Blue Origin's satellite launch plans, indicating strong demand for leading equipment manufacturers [3]. Summary by Sections Recommended Companies - The report suggests a focus on companies such as Northern Huachuang, Sany Heavy Industry, and Zhongwei Company in the mechanical equipment sector, as well as others in the PCB and solar equipment industries [1][2][3]. Industry Trends - The robotics industry is experiencing a significant rebound, with Yushu Technology's IPO materials indicating a revenue increase of 335.36% and a net profit increase of 674.29% for 2025 [1]. - The AI equipment segment is seeing advancements in architecture and design, particularly with NVIDIA's LPU servers, which are expected to enhance PCB demand [2]. - The solar equipment market is benefiting from increased demand driven by major companies like Tesla and innovative projects like Blue Origin's satellite constellation [3]. Market Dynamics - The oil service equipment sector is facing short-term adjustments due to geopolitical tensions but is expected to see long-term demand growth as oil prices remain high and reconstruction efforts in conflict areas increase [7]. - The mechanical equipment industry is projected to benefit from China's increasing foreign investments and the global demand for high-quality equipment, particularly in resource-rich countries [37].

Investment Rating - The report maintains a "Buy" rating for the mechanical equipment industry, with a focus on AI and mechanical equipment investment opportunities [1]. Core Insights - The report emphasizes the potential of AI-driven mechanical equipment, particularly in the robotics sector, where companies like Yushu Technology are showing significant growth in revenue and profitability [1]. - The GTC conference highlighted the increasing demand for AI computing power, which is expected to drive growth in PCB and liquid cooling segments [2]. - The solar equipment sector is poised to benefit from Tesla's procurement of photovoltaic equipment and Blue Origin's satellite launch plans, indicating strong demand for leading equipment manufacturers [3]. Summary by Sections Recommended Companies - The report suggests a focus on companies such as Northern Huachuang, Sany Heavy Industry, and Zhongwei Company, among others, across various segments including robotics, AI devices, and solar equipment [1][2][3]. Industry Trends - The robotics industry is experiencing a significant rebound, with Yushu Technology's IPO materials indicating a revenue increase of 335.36% and a net profit increase of 674.29% for 2025 [1]. - The AI device sector is seeing advancements in architecture and cooling solutions, with Nvidia's LPU architecture expected to enhance performance and drive PCB demand [2]. - The solar equipment market is benefiting from increased demand driven by major companies like Tesla and innovative projects like Blue Origin's satellite constellation [3]. Market Dynamics - The oil service equipment sector is facing short-term adjustments due to geopolitical tensions, but long-term demand is expected to rise as oil prices remain high and reconstruction efforts in conflict areas increase [7]. - The mechanical equipment industry is projected to see significant growth opportunities due to China's increasing foreign investments and the global demand for advanced machinery [37].

Group 1: Macro Insights - The recent FOMC meeting decided to pause interest rate cuts, aligning with market expectations, and highlighted a more optimistic view on inflation, suggesting that the recent energy supply shock is likely a one-time event [2] - There are concerns about potential stagflation, with the Fed raising its PCE inflation forecast and noting that the absolute level of new job creation is too low, posing risks [2] - Powell's comments on his future at the Fed depend on whether the new chairman, Waller, can be confirmed by the Senate in a timely manner, and whether the Trump administration will conclude its investigations [2] Group 2: Company Research - AIA Group (1299.HK) reported a 8.8% year-on-year decline in net profit attributable to shareholders for 2025, while new business value (NBV) increased by 17.1%. The company expects continued growth in NBV driven by agency and partner distribution channels [3] - Haitan International (1882.HK) achieved a 10.0% year-on-year revenue growth and a 7.2% increase in net profit attributable to shareholders for 2025. The company has adjusted its net profit forecasts for 2026-2027 downwards by 6.7% and 6.1% respectively, while introducing a new forecast for 2028 [4] - Geely Automobile (0175.HK) has adjusted its net profit forecasts for 2026 and 2027 down by 0.4% and 0.8% respectively, while introducing a new forecast for 2028. The company remains optimistic about product structure improvements and export growth [4] - Shengmei Shanghai (688082.SH) is progressing steadily in its cleaning equipment business, with new product development on track. The company is expected to see net profit attributable to shareholders of 1.829 billion, 2.285 billion, and 2.667 billion for 2026-2028 [5] - Saint Bella Group (2508.HK), a leader in high-end postpartum care, is well-positioned to benefit from industry upgrades and is expanding into overseas markets. The company forecasts adjusted net profits of 121 million, 178 million, and 279 million for 2025-2027 [6]

Company Ratings - Haitan International (1882) - Buy rating with a target price of HKD 30.00 [2] - Kangzhi Pharmaceutical (867) - Buy rating with a target price of HKD 19.30 [2] Core Insights - Haitan International is expected to maintain steady growth despite industry fluctuations, with a projected revenue of HKD 177.33 billion in 2025, a 10.0% year-on-year increase, and a net profit of HKD 33.01 billion, up 7.2% [7] - Kangzhi Pharmaceutical is returning to a rapid growth trajectory with a revenue increase of 9.9% to HKD 82.1 billion in 2025, driven by exclusive products and innovative drugs [12] Summary by Relevant Sections Haitan International - The company achieved record high performance in 2025, with revenue reaching HKD 177.33 billion and net profit at HKD 33.01 billion, reflecting a 10.0% and 7.2% year-on-year growth respectively [7] - All product lines showed positive growth, with Mars, Jupiter, and Changfei series revenues of HKD 113.17 billion, HKD 24.21 billion, and HKD 21.53 billion, representing year-on-year growth of 8.1%, 16.4%, and 8.9% respectively [8] - The overseas market is expected to be a major growth driver, with international sales increasing by 26.4% to HKD 76.02 billion, accounting for 42.9% of total revenue [9] - The target price is set at HKD 30, maintaining a buy rating, with projected revenues of HKD 195 billion, HKD 208 billion, and HKD 227 billion for 2026-2028 [10] Kangzhi Pharmaceutical - The company reported a revenue increase of 9.9% to HKD 82.1 billion in 2025, with exclusive and innovative drug revenues rising by 23.3% to HKD 56.1 billion [12] - Key product lines showed varied performance, with cardiovascular products up 2.4%, digestive and autoimmune products up 3.3%, and skin health products soaring by 73.2% [13] - The target price is set at HKD 19.3, with a buy rating, reflecting a 40.2% upside potential [14]

Core Viewpoint - The company, Haitai International, is expected to achieve steady growth in its 2025 performance, driven by global supply chain restructuring and demand from certain downstream industries [4]. Group 1: Financial Performance - In 2025, the company reported revenue of 17.73 billion RMB, a year-on-year increase of 10.0% [4]. - The net profit attributable to shareholders reached 3.30 billion RMB, reflecting a year-on-year growth of 7.2% [4]. - Earnings per share stood at 2.07 RMB, with a comprehensive gross margin of 32.7%, up 0.2 percentage points year-on-year [4]. Group 2: Market Demand and Product Performance - The sales revenue from injection molding machines reached 16.90 billion RMB, a 9.7% increase year-on-year, while parts and services generated 840 million RMB, growing by 15.6% [5]. - The Jupiter series products benefited from sustained capacity investments in the new energy vehicle sector, while the Changfei Ya series saw growth due to the recovery in the 3C industry [5]. - The Mars series experienced growth driven by Chinese enterprises expanding overseas [5]. Group 3: International Market Expansion - Domestic revenue was 10.13 billion RMB, showing a slight increase of 0.2% year-on-year, while overseas revenue reached 7.60 billion RMB, marking a significant growth of 26.4% [6]. - The company has adapted its product offerings to meet diverse customer needs, thereby consolidating its market share domestically [6]. - The growth in overseas markets is attributed to the restructuring of global supply chains and the company's early investments in international markets, particularly in Southeast Asia and South America [6].

Group 1: Macro Insights - The recent FOMC meeting decided to pause interest rate cuts, aligning with market expectations, highlighting a more optimistic view on inflation, suggesting that the recent energy supply shock is likely a one-time event [5] - Concerns about potential stagflation were raised, with the Fed increasing its PCE inflation forecast, noting that the absolute level of new job creation is too low, posing risks [5] - Powell's comments on his future at the Fed depend on whether the new chairman, Waller, can receive timely Senate confirmation and whether the Trump administration will conclude its investigations [5] Group 2: Geely Automobile (0175.HK) - In 2025, Geely's total revenue increased by 25.1% year-on-year to 345.23 billion RMB, slightly below the forecast of 353.07 billion RMB [6] - The gross margin remained stable at 16.6%, while net profit attributable to shareholders rose by 0.2% to 16.85 billion RMB, below the forecast of 17.74 billion RMB [6] - Core net profit attributable to shareholders saw a significant increase of 36% year-on-year, reaching 14.41 billion RMB [6] Group 3: Haitian International (1882.HK) - Haitian International reported a revenue of 17.73 billion RMB for 2025, reflecting a year-on-year growth of 10.0% [6] - The net profit attributable to shareholders was 3.30 billion RMB, marking a year-on-year increase of 7.2%, with earnings per share at 2.07 RMB [6] - The company's overall gross margin was 32.7%, up by 0.2 percentage points year-on-year, while the net margin decreased by 0.5 percentage points to 18.6% [6]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 30 HKD, representing a potential upside of 34.6% from the current price of 22.28 HKD [1][4]. Core Insights - The company achieved record-high performance in 2025, with revenue reaching 17.733 billion RMB, a year-on-year increase of 10.0%, and net profit attributable to shareholders at 3.301 billion RMB, up 7.2% [2][3]. - All product lines experienced positive growth, with significant contributions from the Mars, Jupiter, and Changfei series, which saw revenue increases of 8.1%, 16.4%, and 8.9% respectively [2]. - The overseas market is expected to be a major growth driver, with overseas sales growing by 26.4% year-on-year, contributing to 42.9% of total revenue [3]. Financial Performance Summary - For 2025, the company reported a gross margin of 32.7%, an increase of 0.5 percentage points, attributed to improved supply chain management and a higher proportion of overseas sales [2]. - The company forecasts revenues of 19.469 billion RMB, 20.806 billion RMB, and 22.666 billion RMB for 2026, 2027, and 2028 respectively, with net profits projected at 3.638 billion RMB, 3.965 billion RMB, and 4.314 billion RMB [5][6]. - The earnings per share (EPS) is expected to grow from 2.07 RMB in 2025 to 2.28 RMB in 2026, reflecting a year-on-year growth of 10.2% [5]. Market Dynamics - The report highlights that the domestic market is facing challenges due to high base effects, while the overseas market is benefiting from structural adjustments in the global supply chain and the expansion of Chinese enterprises abroad [3]. - The company is well-positioned to capitalize on these trends, particularly in Southeast Asia and South America, where sales have shown significant growth [3].

Group 1 - Investment Rating: Buy for Haitan International (1882) with a target price of HKD 30.00, and Buy for Kangzhe Pharmaceutical (867) with a target price of HKD 19.30 [2] - Haitan International is expected to achieve a revenue of HKD 177.33 billion in 2025, representing a year-on-year growth of 10.0%, and a net profit of HKD 33.01 billion, up 7.2% year-on-year [7][10] - Kangzhe Pharmaceutical's revenue is projected to increase by 9.9% to HKD 82.1 billion in 2025, with a notable growth in exclusive and innovative drug sales [12][14] Group 2 - Haitan International's overseas sales are expected to grow significantly, with a 26.4% increase year-on-year, contributing to 42.9% of total revenue [9] - Kangzhe Pharmaceutical's innovative products are anticipated to drive growth, with new drug approvals expected to significantly boost revenue in the coming years [13][14] - The report highlights the strategic importance of the "ICL+CRO" model for Aidi Kang Holdings, which aims to enhance its value proposition through integrated laboratory services [17][27] Group 3 - Haitan International's gross margin improved to 32.7%, benefiting from supply chain management and increased overseas sales [7] - Kangzhe Pharmaceutical's gross margin decreased to 71.5%, influenced by various factors including increased R&D expenses [12] - Aidi Kang Holdings reported a gross profit margin of 35.8% in 2025, with a focus on optimizing costs and enhancing operational efficiency [17][21] Group 4 - Haitan International's target price reflects a 12/11/10 times forecasted P/E ratio for 2026-28 [10] - Kangzhe Pharmaceutical's target price indicates a potential upside of 40.2% from its current price [14] - Aidi Kang Holdings is positioned to leverage its dual-platform strategy to capture growth in both diagnostic and drug development sectors [36][37]